A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Quinapril (Quinapril)

Quinapril lowers blood pressure by blocking angiotensin-converting enzyme, commonly prescribed for hypertension and heart failure.

First FDA approval2005-03-02
Generic availableYes · 4 mfrs
Shortage statusActive shortage
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$193,713 in CY2024 Part D spend2K claims · 1K beneficiaries · 329 plans surveyed

Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Quinapril used for?

Quinapril lowers blood pressure by blocking angiotensin-converting enzyme, commonly prescribed for hypertension and heart failure.

Is there a generic for Quinapril?

Yes. 16 ANDAs filed at FDA, 4 generic manufacturers currently shipping.

How much does my plan pay for Quinapril?

NADAC pricing data not currently available for this drug.

Is Quinapril on the FDA shortage list?

Yes. Quinapril is currently listed as an active FDA shortage.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

ACE Inhibitor4 alternatives in D1
01
Benazepril
Brand: Lotensin
$0.046Lowest NADAC
10Generic mfrs
$32.8MCY24 Part D spend
Compare →
02
Enalapril
Brand: Epaned
$0.063Lowest NADAC
12Generic mfrs
$56.0MCY24 Part D spend
Compare →
03
Fosinopril
ACE Inhibitor
$0.164Lowest NADAC
5Generic mfrs
$5.8MCY24 Part D spend
Compare →
04
Lisinopril
Brand: Qbrelis
$0.014Lowest NADAC
11Generic mfrs
$387.2MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.